S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

BioCardia (BCDAW) Competitors

$0.02
0.00 (0.00%)
(As of 04/18/2024 ET)

BCDAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW

Should you be buying BioCardia stock or one of its competitors? The main competitors of BioCardia include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

BioCardia vs.

BioCardia (NASDAQ:BCDAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends.

BioCardia and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
BioCardiaN/AN/A
180 Life SciencesN/AN/A

In the previous week, BioCardia's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
BioCardia Neutral
180 Life Sciences Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioCardia
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioCardia$477KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioCardiaN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

BioCardia beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get BioCardia News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCDAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCDAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCDAW vs. The Competition

MetricBioCardiaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$317.24M$4.77B$7.44B
Dividend YieldN/A3.47%2.99%4.00%
P/E RatioN/A232.56253.1519.04
Price / SalesN/A11,380.352,416.1485.85
Price / CashN/A11.3947.2935.12
Price / BookN/A5.864.594.19
Net IncomeN/A-$22.79M$104.50M$214.15M
7 Day PerformanceN/A-2.65%-5.34%-4.90%
1 Month PerformanceN/A-1.94%-4.81%-3.48%
1 Year PerformanceN/A51.51%8.51%3.84%

BioCardia Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-47.6%$0.00N/A0.004Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.11
flat
N/AN/A$0.00$90,718.000.002
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.26
+4.0%
N/A+6.8%$0.00N/A0.00121News Coverage
Positive News
APLMW
Apollomics
0 of 5 stars
$0.03
flat
N/A-77.2%$0.00N/A0.0059
ARTLW
Artelo Biosciences
0 of 5 stars
$0.02
flat
N/AN/A$0.00N/A0.005
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.08
-12.9%
N/A-68.1%$0.00N/A0.0016Positive News
High Trading Volume
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.08
+14.3%
N/A-68.5%$0.00$17,065.000.007Positive News
Gap Down
CTCXW
Carmell
0 of 5 stars
$0.15
flat
N/AN/A$0.00$3.73M0.009
SAVAW
Cassava Sciences
0 of 5 stars
$6.17
+38.6%
N/AN/A$0.00N/A0.0029Positive News
Gap Up
CELUW
Celularity
0 of 5 stars
$0.05
flat
N/A-53.1%$0.00$14.79M0.00225

Related Companies and Tools

This page (NASDAQ:BCDAW) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners